TNF and rheumatoid arthritis: We observed that anti-TNF drugs were the first option for biologic drugs after failure of synthetic DMARDs, which corresponded to 90% of our patients, as recommended by the Brazilian Consensus of Rheumatology (2012) for the treatment of RA [2,5].